VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report)’s stock price shot up 36.4% during mid-day trading on Saturday . The stock traded as high as C$0.17 and last traded at C$0.15. 1,722,555 shares changed hands during mid-day trading, an increase of 726% from the average session volume of 208,641 shares. The stock had previously closed at C$0.11.
VentriPoint Diagnostics Stock Performance
The company has a quick ratio of 6.67, a current ratio of 0.28 and a debt-to-equity ratio of -58.56. The stock has a market capitalization of C$24.33 million, a PE ratio of -4.63 and a beta of 0.39. The firm has a 50 day moving average price of C$0.13 and a 200-day moving average price of C$0.12.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Featured Stories
- Five stocks we like better than VentriPoint Diagnostics
- Using the MarketBeat Stock Split Calculator
- IBM Up 10 Days in a Row: What’s Driving the Winning Streak?
- Health Care Stocks Explained: Why You Might Want to Invest
- Upstart Stock’s Bull Case Just Got a Lot Stronger
- How to Choose Top Rated Stocks
- Higher Gulf Oil Output Puts These Energy Names in Play
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
